The oral tablet introduction hasn't changed screening protocols-the same careful patient selection applies to ensure therapy is medically appropriate, safe, and likely to provide benefit
There is a hormonal answer
Autophagy induction results in enhanced anoikis resistance in models of peritoneal disease
doi: 10.1038/285417a0 7 TakeuchiTGumucioDLYamadaTMeislerMHMinthCDDixonJEet al
Avexitide will be added to Amylyx current pipeline programs that have been in research and development for several years: AMX0035 for the treatment of Wolfram syndrome, AMX0035 for the treatment of progressive supranuclear palsy, and AMX0114, the Companys antisense oligonucleotide targeting calpain-2 for the treatment of amyotrophic lateral sclerosis, or ALS
Always consult with a licensed healthcare provider regarding your health needs, diagnosis, and medication management